证券代码：688307 证券简称：中润光学 公告编号：2025-045 嘉兴中润光学科技股份有限公司 第二届董事会第十一次会议决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会召开情况 嘉兴中润光学科技股份有限公司（以下简称"公司"）于 2025 年 9 月 10 日，向全体董事发出了关于召开公司第二届董事会第十一次会议的通知。该会议 于 2025 年 9 月 16 日以通讯结合现场会议的方式召开，应出席会议董事 7 名，实 际出席会议董事 7 名。本次会议由董事长张平华先生主持，会议的召集和召开符 合法律、行政法规、部门规章和《嘉兴中润光学科技股份有限公司章程》（以下 简称"《公司章程》"）《嘉兴中润光学科技股份有限公司董事会议事规则》（以 下简称"《董事会议事规则》"）的有关规定，合法有效。 二、董事会会议审议情况 （一）审议通过《关于变更公司注册资本的议案》 经审议，鉴于公司 2024 年限制性股票激励计划第一批次已完成归属登记， 公司股本总数拟由 8,800 万股变更为 8,877.4 万股。公司注 ...

Core Viewpoint - Zhongrun Optical (688307.SH) is involved in the upstream of the optical communication industry chain, focusing on precision optical components for various laser applications, including AI optical modules currently in the R&D phase [1] Group 1: Company Overview - Zhongrun Optical's products are essential for manufacturing optical modules, which are critical components in the laser application market [1] - The company is engaged in the development of optical components such as prisms and filters for AI optical modules [1] Group 2: Industry Context - The downstream laser application market includes sectors like laser processing equipment, optical communication devices and equipment, laser measurement devices, and laser medical devices [1]

Group 1 - The company, Zhongrun Optical (688307.SH), primarily engages in the design and production of precision optical lenses [1] - Optical lenses have a wide range of applications, serving as the entry point for video and image information in various artificial intelligence devices [1] - The company offers customized development and mass production services for optical lens products to various clients [1] Group 2 - Currently, the company does not have any products applied in Apple smartphones [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 嘉兴中润光学科技股份有限公司 2024年限制性股票激励计划第一个归属期归属结果暨股票上市公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次股票上市类型为股权激励股份；股票认购方式为网下，上市股数为774,000股。 本次股票上市流通总数为774,000股。 ● 本次股票上市流通日期为2025年9月17日。 根据中国证券监督管理委员会、上海证券交易所、中国证券登记结算有限责任公司上海分公司相关业务 规定，嘉兴中润光学科技股份有限公司（以下简称"公司"）于近日收到中国证券登记结算有限责任公司 上海分公司出具的《证券变更登记证明》，公司完成了2024年限制性股票激励计划第一个归属期的股份 登记工作。现将有关情况公告如下： 证券代码：688307 证券简称：中润光学 公告编号：2025-043 一、本次限制性股票归属的决策程序及相关信息披露 （1）2024年8月9日，公司第二届董事会第三次会议审议通过了《关于〈2024年限制性股票激励计划 （草案）〉及其 ...

证券代码：688307 证券简称：中润光学 公告编号：2025-043 嘉兴中润光学科技股份有限公司 2024 年限制性股票激励计划第一个归属期归属结果 暨股票上市公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 根据中国证券监督管理委员会、上海证券交易所、中国证券登记结算有限责 任公司上海分公司相关业务规定，嘉兴中润光学科技股份有限公司（以下简称"公 司"）于近日收到中国证券登记结算有限责任公司上海分公司出具的《证券变更登 记证明》，公司完成了 2024 年限制性股票激励计划第一个归属期的股份登记工作。 现将有关情况公告如下： 一、本次限制性股票归属的决策程序及相关信息披露 （1）2024 年 8 月 9 日，公司第二届董事会第三次会议审议通过了《关于<2024 年限制性股票激励计划（草案）>及其摘要的议案》《关于<2024 年限制性股票激 励计划实施考核管理办法>的议案》《关于提请公司股东大会授权董事会办理公司 2024 年限制性股票激励计划有关事项的议案》。 同日，公司第二届监事会第三次会议审议通 ...

嘉兴中润光学科技股份有限公司公告2024年限制性股票激励计划第一个归属期归属结果及股票上市情 况。本次归属激励对象95人，归属股份77.4万股，占获授限制性股票数量的40%，股票来源为向激励对 象定向发行A股普通股。归属股票将于2025年9月17日上市流通，上市流通股数77.4万股。本次归属后公 司股本总数由8800万股增至8877.4万股，控股股东及实际控制人未变。天健会计师事务所已完成验资， 归属未对公司最近一期财务状况及经营成果构成重大影响。 ...

证券代码：688307 证券简称：中润光学 公告编号：2025-042 嘉兴中润光学科技股份有限公司 关于变更签字会计师的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 嘉兴中润光学科技股份有限公司（以下简称"公司"）于 2025 年 3 月 28 日召开了第二届董事会第七次会议，于 2025 年 4 月 18 日召开了 2024 年年度股 东大会，审议通过了《关于续聘 2025 年度会计师事务所的议案》，同意聘请天 健会计师事务所（特殊普通合伙）（以下简称"天健所"）为公司 2025 年度财 务报表及内部控制审计机构。具体内容详见公司于 2025 年 3 月 29 日在上海证券 交易所网站（www.sse.com.cn）披露的《关于续聘 2025 年度会计师事务所的公 告》（公告编号 2025-008）。 近日，公司收到天健所送达的《关于变更签字注册会计师的函》，现将相关 变更情况告知如下： 一、本次签字会计师变更的基本情况 天健所作为公司 2025 年度财务报表和 2025 年末财务报告内部控制审计机 构，原委派韦 ...

Core Viewpoint - Zhongrun Optics (688307) reported a revenue increase of 29.73% year-on-year for the first half of 2025, with a total revenue of 250 million yuan and a net profit of 20.56 million yuan, reflecting a modest growth of 0.98% [1] Financial Performance - Total revenue for the first half of 2025 reached 250 million yuan, up from 192 million yuan in the same period of 2024, marking a 29.73% increase [1] - Net profit attributable to shareholders was 20.56 million yuan, slightly up from 20.36 million yuan, indicating a 0.98% growth [1] - The second quarter alone saw a revenue of 138 million yuan, a 21.69% increase year-on-year, with a net profit of 10.27 million yuan, up 10.69% [1] - The gross profit margin was 32.33%, down 0.94% from the previous year, while the net profit margin decreased by 19.64% to 8.52% [1] - Total operating expenses (sales, management, and financial expenses) amounted to 30.07 million yuan, accounting for 12.04% of revenue, an increase of 3.9% year-on-year [1] Balance Sheet Highlights - Cash and cash equivalents increased significantly by 149.81% to 405 million yuan [1] - Accounts receivable rose by 16.82% to 93.99 million yuan, with accounts receivable to net profit ratio reaching 175.92% [1][3] - Interest-bearing liabilities decreased by 38.16% to 14.93 million yuan [1] Shareholder Metrics - Earnings per share remained stable at 0.23 yuan, while the operating cash flow per share dropped significantly by 69.93% to 0.24 yuan [1] - Book value per share increased by 3.11% to 9.74 yuan [1] Business Model and Market Position - The company's return on invested capital (ROIC) was reported at 4.97%, indicating a relatively weak capital return [2] - Historical data shows a median ROIC of 10.03% since the company went public, with the lowest ROIC recorded at 4.12% in 2023 [1][2] - The company relies heavily on research and development for its business performance, necessitating further investigation into the underlying drivers of this model [2]

Group 1 - The company Zhongrun Optical (688307.SH) reported a total operating revenue of 250 million yuan for the first half of 2025, representing a year-on-year increase of 29.73% [1] - The net profit attributable to shareholders of the parent company was 20.5646 million yuan, showing a year-on-year growth of 0.98% [1] - The basic earnings per share were 0.23 yuan, and the company proposed a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders [1]

Group 1 - The core purpose of the foreign exchange hedging business is to mitigate risks associated with exchange rate fluctuations due to the company's expanding overseas operations and increasing foreign currency transactions [1][2] - The company plans to conduct foreign exchange hedging transactions involving various currencies, primarily including the US dollar, to protect against exchange rate risks [1][2] - The total amount for the foreign exchange hedging business is capped at 20 million USD or equivalent foreign currency, with a validity period of 12 months from the board's approval [2][5] Group 2 - The company will only engage with qualified financial institutions approved by regulatory authorities for foreign exchange hedging transactions, ensuring low counterparty risk [3][4] - A comprehensive risk management framework has been established, including internal controls and procedures to minimize operational risks associated with foreign exchange hedging [3][4] - The company will continuously monitor market prices and assess the risk exposure of foreign exchange derivatives, reporting any anomalies to management [3][4] Group 3 - The foreign exchange hedging business is aligned with the company's operational needs and aims to enhance financial stability without harming the interests of shareholders [4][6] - The board and audit committee have approved the foreign exchange hedging proposal, confirming that it meets the company's business development requirements [5][6] - The company has developed a management system for foreign exchange hedging, detailing principles, approval authority, and risk handling procedures [4][6]